NUVISAN The Science CRO
Matthias J. E. Arlt is currently working as a Principal Scientist / Lab Head in Therapeutic Research at Nuvisan. Prior to this, Matthias was the Head of Therapeutic Oncology Research Lab at Bayer Pharmaceuticals and a Senior Scientist at ETH Zurich. With a background in translational research on acute tendon injury, healing, and chronic tendon disease, Matthias has also worked in various research roles at Universitätsklinik Balgrist, Technical University of Munich, and Free University of Berlin. Matthias holds a degree in Cancer Biology from Freie Universität Berlin and has experience supervising students at various academic levels.
This person is not in the org chart
This person is not in any offices
NUVISAN The Science CRO
1 followers
Founded in Europe with more than 40 years of experience, NUVISAN is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain. With more than 1.000 employees distributed over six locations in Germany and France including our drug discovery hub in Berlin as well as with local experts situated in Latin America, NUVISAN is pleased to offer the following portfolio of services: • Drug discovery & research - Discovery pharmacology - Discovery bioscience - Screening - Life science chemistry - Translation research - Digital life science - Toxicology - DMPK • Non-clinical studies • Pharmaceutical analysis • Topical formulation development • Chemical development with GMP manufacturing (3-10kg) • Bioanalytical labs • GMP manufacturing (up to 50Kg) • Clinical trial supplies • Phase 1 and 2 clinical studies and beyond Our services can be provided as stand-alone or integrated solutions and can be customized to your project. Email us at hello@nuvisan.com for more.